Media

Very few will dispute that after China, the next big emerging market is India. With 1.3bn population and possibly surpassing China in population by 2025, India will be in the next big market to watch in Asia. On a macro level, ...

Mandala Capital's portfolio company Arcadia Biosciences is collaborating with Ardent Mills, North American’s leading flour-milling and ingredient company, to develop and commercialize innovative wheat traits. Their first project focuses on extending the shelf life and improving the flavor of whole ...

Mandala Capital, in collaboration with The Chamber of Commerce and Industry, Invest India, the Government of India, and the Government of Gujarat hosted the first Food and Agriculture Investor Meet symposium at the Office of the Consulate General of India, ...

Verdeca, a joint venture between Mandala Capital's portfolio company Arcadia Biosciences and Bioceres receives approval to integrate HB4® drought tolerant Soybeans with terbicide tolerance in Argentina. This allows Verdeca to incorporate both glyphosate and glufosinate-ammonium tolerance into the HB4 trait.

Uday Garg of Mandala Capital had an exclusive interview with VC Circle on "Why investors will flock to food processing players".

Indian Agriculture: Ripe for a Transformation? Indian agricultural growth and the related sectoral investment opportunities have always held a promise of greatness that has, until now, remained an elusive destiny. For the year that ended March 2018, agriculture GDP grew by ...

Mandala Capital was featured in the Business Standard. "Mandala Capital, a private equity firm with focus on agri and food value chain investments in India, is expecting partial or full exits from around five companies out of the eight investments ...